Ondine Biomedical President and CTO Nicolas Loebel joined Steve Darling from Proactive to share news the company is working with a team at the University of Navarra in Spain on a clinical trial using the company’s Steriwave technology to stop the replication of SARS-CoV-2 in high-risk viral carriers.
Loebel telling Proactive this technology uses photodisinfection to kill germs, including Covid. So far, the Lab-based evaluations showed Steriwave to be effective, and now they look to gather clinical data in people with Covid.